Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine. (Q43712514)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

29 February 2020

main subject

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

J Vidal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R Gisbert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Muñoz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Maciá

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Gómez-Codina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

12 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

637-643

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-013-1128-8

29 February 2020

exact match

0 references

cites work

A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Prognostic impact of circulating tumor cells in patients with small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1128-8

Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells

21 January 2018

1 reference

12 December 2020

Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood

1 reference

12 December 2020

Circulating tumor cells in solid tumor in metastatic and localized stages

1 reference

12 December 2020

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial

1 reference

12 December 2020

10.1007/S12094-013-1128-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217975%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference